# Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

> **NCT07298473** · NA · RECRUITING · sponsor: **Medtronic Cardiac Ablation Solutions** · enrollment: 400 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)
- Persistent Atrial Fibrillation
- Paroxysmal Atrial Fibrillation (PAF)

## Interventions

- **DEVICE:** Sphere-9 Catheter Ablation

## Key facts

- **NCT ID:** NCT07298473
- **Lead sponsor:** Medtronic Cardiac Ablation Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-08
- **Primary completion:** 2028-03-29
- **Final completion:** 2028-03-29
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07298473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07298473, "Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07298473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*